Fierce Pharma March 7, 2024
Kevin Dunleavy

With President Joe Biden girding for a significant challenge from former President Donald Trump in his reelection bid in November, Biden undoubtedly will emphasize his success in leading the passage of the Inflation Reduction Act (IRA) and its measures to cut healthcare costs.

Tonight, as Biden makes his State of the Union address, he is expected to reveal a push to double down on his drug price initiatives outlined in the IRA. According to HuffPost and CBS News, citing senior administration officials, Biden will urge Congress to expand the Medicare drug price negotiations to 50 drugs per year, instead of the 20 previously specified by the IRA.

Negotiations currently are underway between the Centers for Medicare & Medicaid Services and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
What to know about Trump's surgeon general nominee
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Trump's pick for CDC director: 10 things to know
Trump tariffs could drive up generic drug costs: 5 takeaways
Senators urge Congress to avert Medicare physician pay cut

Share This Article